Business
The FDA Pulled Authorization for the Covid-19 Monoclonal Antibody Made by Vir and ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'The FDA pulled authorization for the Covid-19 monoclonal antibody made by Vir and GlaxoSmithKline in states where BA.2 dominates because it is unlikely to fight the omicron subvariant ...'
The FDA pulled authorization for the Covid-19 monoclonal antibody made by Vir and GlaxoSmithKline in states where BA.2 dominates because it is unlikely to fight the omicron subvariant https://t.co/gwOz1PIHYE— Bloomberg (@business) March 25, 2022
(The above story first appeared on LatestLY on Mar 26, 2022 03:12 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
